Proteomics approaches to characterize the immune responses in cancer
- PMID: 35390423
- DOI: 10.1016/j.bbamcr.2022.119266
Proteomics approaches to characterize the immune responses in cancer
Abstract
Despite the dynamic development of cancer research, annually millions of people die of cancer. The human immune system is the major 'guard' against tumor development. Unfortunately, cancer cells have the ability to evade the immune system and continue to grow. The proper understanding of the intricate immune response in tumorigenesis remains the holy grail of cancer immunology and designing effective immunotherapy. To decode the immune responses in cancer, in recent years, proteomics studies have received considerable attention. Proteomics studies focus on the detection and quantification of proteins, which are the effectors of biological functions, and as such, are proven to reflect the cell state more accurately, in comparison to genomic or transcriptomic studies. In this review, we discuss the proteomics studies applied to characterize the immune responses in cancer and tumor immune microenvironment heterogeneity. Further, we describe emerging single-cell proteomics approaches that have the potential to be applied in cancer immunity studies.
Keywords: Cancer; Immunity; Immunotherapy; Proteomics; Single-cell; T cells.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Single-Cell Proteomics for Cancer Immunotherapy.Adv Cancer Res. 2018;139:185-207. doi: 10.1016/bs.acr.2018.04.006. Epub 2018 May 23. Adv Cancer Res. 2018. PMID: 29941105 Review.
-
Proteomics to study cancer immunity and improve treatment.Semin Immunopathol. 2023 Mar;45(2):241-251. doi: 10.1007/s00281-022-00980-2. Epub 2023 Jan 4. Semin Immunopathol. 2023. PMID: 36598558 Free PMC article. Review.
-
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.Front Immunol. 2018 Jun 4;9:1288. doi: 10.3389/fimmu.2018.01288. eCollection 2018. Front Immunol. 2018. PMID: 29915603 Free PMC article. Review.
-
Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.Acc Chem Res. 2020 Nov 17;53(11):2546-2557. doi: 10.1021/acs.accounts.0c00475. Epub 2020 Oct 16. Acc Chem Res. 2020. PMID: 33063517 Free PMC article.
-
Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.Front Immunol. 2018 May 4;9:946. doi: 10.3389/fimmu.2018.00946. eCollection 2018. Front Immunol. 2018. PMID: 29780391 Free PMC article. Review.
Cited by
-
Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer.J Ovarian Res. 2024 Sep 28;17(1):190. doi: 10.1186/s13048-024-01518-w. J Ovarian Res. 2024. PMID: 39342345 Free PMC article.
-
Comparative proteomic profiling of the ovine and human PBMC inflammatory response.Sci Rep. 2024 Jun 28;14(1):14939. doi: 10.1038/s41598-024-66059-0. Sci Rep. 2024. PMID: 38942936 Free PMC article.
-
The Role of Proteomics and Genomics in the Development of Colorectal Cancer Diagnostic Tools and Potential New Treatments.ACS Pharmacol Transl Sci. 2025 Apr 10;8(5):1227-1250. doi: 10.1021/acsptsci.4c00686. eCollection 2025 May 9. ACS Pharmacol Transl Sci. 2025. PMID: 40370990 Review.
-
Variations in Circulating Tumor Microenvironment-Associated Proteins in Non-Muscle Invasive Bladder Cancer Induced by Mitomycin C Treatment.Int J Mol Sci. 2025 Aug 1;26(15):7413. doi: 10.3390/ijms26157413. Int J Mol Sci. 2025. PMID: 40806542 Free PMC article.
-
Characterization and Optimization of Multiomic Single-Cell Epigenomic Profiling.Genes (Basel). 2023 Jun 10;14(6):1245. doi: 10.3390/genes14061245. Genes (Basel). 2023. PMID: 37372428 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical